Such an event indicates the probability of the existence of certain continuous conditions inside the cancer cells that makes them exhibit this mTOR kinase ligand-specific modulation, resulting in these cells being the significant therapeutic target for different mTOR inhibitors. The gene discussed is MTOR; the disease is cancer.